Date(s)

11 Dec 2021

Program Language

Russian

Meeting type

Virtual Meeting

Organizer

Moscow HIV Clinical Forum 2021

Related Enduring Materials

Overview

The Moscow HIV Clinical Forum 2021 provided an independent scientific program involving the world’s leading experts. Specifically designed for Russian HIV healthcare professionals, the forum focused on optimizing treatment for their patients.

This program featured challenging plenary lectures followed by ample time for Q&A and debate, stimulating interaction, and knowledge-sharing within the HIV-treating community in Russia. The program included virtual networking opportunities for community-building, providing delegates with the unique opportunity to meet their colleagues in a focused and scientific setting.

The Moscow HIV Clinical Forum is part of a series of interactive programs that feature regional experts and provide an independent scientific program on emerging topics in HIV. HIV clinicians and allied healthcare professionals will receive updates on the latest developments related to HIV management. The program provides a platform for delegates to share their clinical experience and present results from the ongoing and completed research studies.

Furthermore, the HIV Clinical Forum provides an educational setting where healthcare professionals can acquire specific skills that will enhance their capabilities to interpret research results and even develop new research projects.

Committee

Anton Pozniak, MD, FRCP

Chelsea and Westminster Hospital, United Kingdom

Elena Orlova-Morozova, MD, PhD

Moscow Regional Center for the Prevention and Control of AIDS and Infectious Diseases, Russia

General Information

COVID-19 Update

Responding to the COVID-19 situation, the Moscow HIV Clinical Forum 2021: Optimizing Treatment will be held as a virtual meeting.

We are available to answer any questions or concerns that you may have about your participation at the Moscow HIV Clinical Forum 2021: Optimizing Treatment. For more information, please contact Ms. Natalia Voronina at natalia.voronina@amededu.com .

To stay updated on developments about this meeting, make sure that you are signed up for our newsletter.

Who Should Attend?

Primary: Medical doctors involved in the management and treatment of people living with HIV in the region

Secondary: Researchers

Tertiary: Healthcare workers, clinical virologists, microbiologists, scientists, pharmacologists, nurses, post-doctoral researchers, students, and other healthcare professionals involved in treating people living with HIV.

Meeting Objectives

With the HIV Clinical Forum program we aim to:

- Build a community of healthcare professionals devoted to providing optimal clinical care for their patients;

- Create a platform for interactive information exchange on novel treatment options; and

- Translate the latest research achievements into clinical guidance for the optimal management of individuals living with HIV.

Learning Objectives

After participating in the HIV Clinical Forum, participants will be able to:

- Understand the clinical data supporting novel treatment strategies;

- Describe the pros and cons of novel treatment strategies;

- Understand how to integrate novel treatment strategies into routine patient care;

- Be knowledgeable of the clinical data supporting long-acting injectable regimens;

- Identify patients who might best benefit from long acting injectable regimens;

- Know how best to integrate injectable drugs in to routine clinical care;

- Improve their skills in defining and identifying people living with HIV with limited treatment options; and

- Stay informed on new drug options and understand how to implement them for treatment experienced people living with HIV.

Practical Information

We trust that the following information (in alphabetical order) will assist you in organizing your participation in the Moscow HIV Clinical Forum 2021: Optimizing Treatment.

Certificate of Attendance

A certificate of attendance will be sent to participants by e-mail shortly after the forum meeting.

Disclaimer

This forum meeting is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of meeting, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from the meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending this forum meeting.

Language

The official language of this meeting is Russian.

Liability and Insurance

By registering for this forum meeting, participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance if this forum is either physical or hybrid. Participants are advised to take out their own insurance policies.

Payment and Procedure of Online Registration

The registration fee is waived for all healthcare professionals. You will get a confirmation of your registration within 1-5 business days. If you did not receive a confirmation, please contact Ms. Natalia Voronina at natalia.voronina@amededu.com.

Photographs, Audio, and Video Recording

Photographs, as well as audio and video recordings, are not permitted at the official forum meeting sessions. Only the official medical writer, appointed by the organizer, may make recordings. All presentations will be posted on the forum website as soon as possible after the meeting is finished, provided that the speaker has given their permission to do so.

Enduring Materials

Program

Saturday, 11 December 2021

Opening of the Program -

Session 1: Working Towards the 90-90-90 Goals - Prevention - 10:05

10:05 MSK

HIV Prevention - Virologist Perspective

Alina Kirichenko, MD

Central Research Institute of Epidemiology, Russia

Видео

Презентация

10:20 MSK

HIV Prevention - Clinician Perspective

Jean-Michel Molina, MD, PhD

Saint-Louis/Lariboisière Hospitals and University of Paris, France

Видео

Презентация

10:35 MSK

Awareness, Attitudes, and Experiences of Implementing PrEP in Russia

Ulyana Kuimova, PhD

Central Research Institute of Epidemiology Rospotrebnadzor, Russia

Видео

10:50 MSK

Roundtable Discussion and Q/A with Speakers from Session 1

Alina Kirichenko, MD

Central Research Institute of Epidemiology, Russia

Jean-Michel Molina, MD, PhD

Saint-Louis/Lariboisière Hospitals and University of Paris, France

Ulyana Kuimova, PhD

Central Research Institute of Epidemiology Rospotrebnadzor, Russia

Session 2: Working Towards the 90-90-90 Goals - Treatment - 11:20

11:20 MSK

HIV Treatment - Importance Of U=U Message

Jens Lundgren, MD, DMSc

University of Copenhagen, Denmark

Видео

11:35 MSK

Switching First Line, Why and to What

Anton Pozniak, MD, FRCP

Chelsea and Westminster Hospital, United Kingdom

Видео

Презентация

11:50 MSK

Regional Focused Topic: Switching to Second Line with Virological Failure if Resistance Tests are Not Available

Natalia Sizova, PhD

Saint-Petersburg AIDS Center, Russia

Видео

Презентация

12:05 MSK

Roundtable Discussion and Q/A with Speakers from Session 2

Jens Lundgren, MD, DMSc

University of Copenhagen, Denmark

Anton Pozniak, MD, FRCP

Chelsea and Westminster Hospital, United Kingdom

Natalia Sizova, PhD

Saint-Petersburg AIDS Center, Russia

Session 3: Management of Co-Infections - 12:40

12:40 MSK

Management of PLWH Co-Infected With SARS-CoV-2

Laura Waters, MD, FRCP

Central & North West London NHS Foundation Trust, United Kingdom

Видео

Презентация

12:55 MSK

Hepatitis Co-Infections

Jürgen Rockstroh, MD

University of Bonn, Germany

Видео

Презентация

13:10 MSK

HIV/TB Co-Infection: Clinical Case

Greg Kaminskiy, MD, PhD

National Medical Research Center for Phthisiopulmonology and Infectious Diseases under the Ministry of Health of the Russian Federation, Russia

Видео

Презентация

13:25 MSK

Roundtable Discussion and Q/A with Speakers from Session 3

Laura Waters, MD, FRCP

Central & North West London NHS Foundation Trust, United Kingdom

Jürgen Rockstroh, MD

University of Bonn, Germany

Greg Kaminskiy, MD, PhD

National Medical Research Center for Phthisiopulmonology and Infectious Diseases under the Ministry of Health of the Russian Federation, Russia

Closure of the Program -

Committees

Program Director

Anton Pozniak, MD, FRCP

Chelsea and Westminster Hospital, United Kingdom

Local Chair

Elena Orlova-Morozova, MD, PhD

Moscow Regional Center for the Prevention and Control of AIDS and Infectious Diseases, Russia

The Program Chairs are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the forum meeting and identify interesting topics and candidate speakers.

Support

Acknowledgment

"This educational activity is supported by an independent educational grant from ViiV Healthcare. ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity."

«Эта образовательная деятельность поддерживается независимым образовательным грантом от ViiV Healthcare. ViiV Healthcare не участвовала в разработке содержания или отборе преподавателей для этой образовательной деятельности».

Endorsers